ArticleLiver cancer2019

A New Treatment Option for Intermediate-Stage Hepatocellular Carcinoma with High Tumor Burden: Initial Lenvatinib Therapy with Subsequent Selective TACE.

Masatoshi KudoPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.